EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent antibody positivity and gastrointestinal symptoms predicted progression of potential celiac disease to celiac disease

Sofia Kröger, Laura Kallio, Linnea Aitokari, Marleena Repo, Heini Huhtala, Oona Kähkönen, Veronika Salmio, Katri Kaukinen, Kalle Kurppa, Laura Kivelä

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2025.04.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Sofia Kröger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Oncology, Hospital Nov…. Hauptthemen laut MEDLINE: Celiac Disease, Autoantibodies, Transglutaminases. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sigrid Juséliuksen Säätiö, Research Council of Finland, Finnish Cultural Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The natural history of potential celiac disease is poorly defined. AIMS: To study factors predicting progression of potential celiac disease to overt celiac disease. METHODS: Medical data were collected from patients with potential celiac disease defined as positive tissue transglutaminase and/or endomysial autoantibodies without diagnostic duodenal villous atrophy. RESULTS: Of 158 patients with potential celiac disease (61 % women, median age 16 years, range 1-81 years), follow-up data were available for 128. The median follow-up time in patients not receiving a diagnosis was 14.6 years, and the median time until celiac disease diagnosis was 2.1 years. Serology normalized spontaneously in 38 %, while 61 % remained seropositive and 2 % began a gluten-free diet. Seventy-three patients underwent repeat endoscopy and 63 % of them received a celiac disease diagnosis. Those with later celiac disease diagnosis reported symptoms more often (84 % vs. 62 % p = 0.020) and were less frequently screen-detected (23 % vs. 52 %, p = 0.004) at their first endoscopy. During follow-up, they experienced persistent gastrointestinal symptoms more often (54 % vs. 27 %, p = 0.006) and remained seropositive (50 % vs. 16 %, p = 0.018). CONCLUSION: During long-term follow-up, 63 % of the patients undergoing repeat endoscopy developed celiac disease. Predictive factors included baseline symptoms and persistence of gastrointestinal symptoms and sustained seropositivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseAutoantibodiesTransglutaminasesHumansFemaleAdultMaleDisease ProgressionAdolescentMiddle AgedAgedChildYoung AdultChild, PreschoolAged, 80 and overInfantDiet, Gluten-FreeFollow-Up StudiesEndoscopy, GastrointestinalGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2

Stichwörter der Autor:innen

Gluten-freeHistologyPrognosisSeropositivity

Substanzen

AutoantibodiesTransglutaminasesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2

Autor:innen und Institutionen

  • Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Oncology, Hospital Nova of Central Finland, Wellbeing Services County of Central Finland, Jy…
  • Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland.
  • Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland; V…
  • Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland; D…
  • Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Internal Medicine, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tamp…

Förderung

  • Sigrid Juséliuksen Säätiö
  • Research Council of Finland
  • Finnish Cultural Foundation
  • Tays
  • Keliakialiitto
  • Paivikki and Sakari Sohlberg Fundation
  • Paulon Säätiö
  • Pirkanmaan Rahasto

Zitieren

APA

Kröger, S., Kallio, L., Aitokari, L., Repo, M., Huhtala, H., Kähkönen, O., Salmio, V., Kaukinen, K., Kurppa, K., & Kivelä, L. (2025). Persistent antibody positivity and gastrointestinal symptoms predicted progression of potential celiac disease to celiac disease. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.04.004

Vancouver

Kröger S, Kallio L, Aitokari L, Repo M, Huhtala H, Kähkönen O, et al. Persistent antibody positivity and gastrointestinal symptoms predicted progression of potential celiac disease to celiac disease. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.04.004

BibTeX
@article{Krger2025,
  author = {Kröger, Sofia and Kallio, Laura and Aitokari, Linnea and Repo, Marleena and Huhtala, Heini and Kähkönen, Oona and Salmio, Veronika and Kaukinen, Katri and Kurppa, Kalle and Kivelä, Laura},
  title = {Persistent antibody positivity and gastrointestinal symptoms predicted progression of potential celiac disease to celiac disease},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2025.04.004}
}
Kostenlos starten →